Medical Condition News

RSS

Space station study tests colorectal cancer tumor avatars in microgravity

Researchers from Wake Forest Institute for Regenerative Medicine (WFIRM) are studying how microgravity affects how models of colorectal cancer cells respond to chemotherapy aboard the International Space Station.

9 Nov 2026

Liver transplants dramatically extend survival for alcohol-associated liver disease

People with alcohol-associated liver disease who received a liver transplant survived years longer than those who did not, but there are disparities in which patients receive a transplant.

9 Nov 2026

Monthly binge drinking increases advanced liver fibrosis risk in women

Women who consume four or more alcohol drinks on a single occasion once a month or more have increased odds of advanced liver fibrosis, a new study suggests.

9 Nov 2026

Blood biomarker tracks nerve damage from oxaliplatin-containing adjuvant chemotherapy

Oxaliplatin can cause numbness, tingling, and pain in the hands and feet, with consequences for mobility, work, and quality of life.

9 Nov 2026

Cannabis use increases mortality risk in alcohol-associated hepatitis patients

People with alcohol-associated hepatitis are more likely to die from the disease if they use cannabis. A large multinational study just published in Alcohol: Clinical and Experimental Research is the first to identify active substance use, particularly cannabis use, by patients as an independent predictor of death in patients with alcohol-associated hepatitis.

9 Nov 2026

Stanford study challenges long-held dogma on causes of concussions

Concussions - essentially mild traumatic brain injuries - are among the most common injuries sustained on athletic fields. In the U.S., an estimated 3.8 million sports-related concussions occur every year.

9 Nov 2026

New monoclonal antibody therapy significantly lowers patient triglyceride levels

A phase 2b clinical trial led by Mass General Brigham Heart and Vascular Institute researchers shows that a monoclonal antibody therapy called MAR001 can significantly reduce triglyceride levels within 12 weeks for patients with high triglyceride levels.

9 Nov 2026

Could a daily supplement keep blood vessels healthier as we age?

The study highlights a multi-compound nutritional supplement's potential to improve blood vessel function and lower blood pressure, aiding vascular health.

9 Nov 2026

Intravenous blood thinner improves heart recovery after cardiogenic shock

For heart attack patients who develop cardiogenic shock-the most serious complication of a heart attack-cangrelor, a potent intravenous blood thinner, resulted in better recovery of heart function when compared to oral antiplatelet therapy.

9 Nov 2026

New mRNA therapy reawakens heart muscle cells to repair damage

Scientists have developed a treatment that 'reawakens' heart muscle cells so they start to divide and help repair damaged muscle.

9 Nov 2026

AI tool uses emergency room narratives to predict PTSD risk

An AI tool can analyze patients' narratives about injuries that sent them to the emergency room to predict who will later develop post-traumatic stress disorder (PTSD), a new study found.

9 Nov 2026

Alliance highlights clinical trials advancing lung cancer detection and care

Lung cancer remains the leading cause of cancer-related deaths in the United States, but advances in early detection and treatment are improving the outlook for patients.

9 Nov 2026

Better reimbursement programs can improve access to cancer clinical trials

New research reveals that participating in cancer clinical trials can cause financial burdens that are shaped by both socioeconomic and logistical factors.

9 Nov 2026

Modified zinc finger protein reduces brain plaques in Alzheimer's mice

A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease.

9 Nov 2026

Combat Medical reports 68% high-grade recurrence-free survival at 12 months in BCG-unresponsive non-muscle invasive bladder cancer study

Combat Medical (Combat), a medical device company optimizing the delivery and efficacy of cancer therapeutics, today announced new real-world data showing 68% high-grade recurrence-free survival (HG-RFS) at 12 months in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) after hyperthermic intravesical chemotherapy (HIVEC®) with mitomycin C.

9 Nov 2026